{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:11:11Z","timestamp":1789103471843,"version":"build-2803163510"},"reference-count":27,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"a Grant-in-Aid for Clinical Research from Miyazaki University Hospital","award":["not available"],"award-info":[{"award-number":["not available"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever in China, Korea, and Japan. To date, no standardized treatment protocol for SFTS has been established. Corticosteroids (CS) may be administered to patients with SFTS and hemophagocytic syndrome, but its effectiveness and safety are still debatable. We conducted a retrospective case series review at four medical facilities in Miyazaki, Japan. Based on the medical records, clinical data, including the patients background, symptoms, physical findings, laboratory data at initial presentation, treatment, and outcome, were compared between the CS-treated and the non-CS-treated group. A total of 47 patients with confirmed SFTS in each hospital were enrolled in this study; there were 14 fatal cases and 33 nonfatal cases. The case fatality ratio was 29.8%. After adjusting patients\u2019 background by propensity score matching, the case fatality ratio was higher (p = 0.04) and complications of secondary infections, including invasive pulmonary aspergillosis, tended to be more frequent (p = 0.07) in the CS-treated group than in the non-CS-treated group. These data suggested that administration of CS to patients with SFTS should be carefully considered.<\/jats:p>","DOI":"10.3390\/v13050785","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T22:29:07Z","timestamp":1619648947000},"page":"785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Corticosteroids May Have Negative Effects on the Management of Patients with Severe Fever with Thrombocytopenia Syndrome: A Case\u2013Control Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1615-5088","authenticated-orcid":false,"given":"Takeshi","family":"Kawaguchi","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Infectious Diseases, and Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1116-5818","authenticated-orcid":false,"given":"Kunihiko","family":"Umekita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Infectious Diseases, and Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Miyazaki 880-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Nichinan Hospital, Miyazaki 887-0013, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Miyazaki Prefectural Nobeoka Hospital, Miyazaki 882-0835, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"Showa University Research Administration Center, Showa University, Tokyo 142-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Okayama","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Infectious Diseases, and Laboratory Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki 889-1692, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011\u20132017: A prospective observational study","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Choi, S.J., Park, S.W., Bae, I.G., Kim, S.H., Ryu, S.Y., Kim, H.A., Jang, H.C., Hur, J., Jun, J.B., and Jung, Y. (2016). Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013\u20132015. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005264"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kato, H., Yamagishi, T., Shimada, T., Matsui, T., Shimojima, M., Saijo, M., Oishi, K., and SFTS Epidemiological Research Group-Japan (2016). Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013\u20132014. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0165207"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3201\/eid2604.191011","article-title":"Severe Fever with Thrombocytopenia Syndrome, Japan, 2013\u20132017","volume":"26","author":"Kobayashi","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcv.2013.10.024","article-title":"Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China","volume":"59","author":"Cui","year":"2014","journal-title":"J. Clin. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zhang, S.F., Yang, Z.D., Huang, M.L., Wang, Z.B., Hu, Y.Y., Miao, D., Dai, K., Du, J., Cui, N., and Yuan, C. (2019). Preexisting chronic conditions for fatal outcome among SFTS patients: An observational Cohort Study. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007434"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/infdis\/jis472","article-title":"Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients","volume":"206","author":"Gai","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e18727","DOI":"10.1097\/MD.0000000000018727","article-title":"Analysis of the laboratory indexes and risk factors in 189 cases of severe fever with thrombocytopenia syndrome","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1038\/s41598-017-06921-6","article-title":"Downregulation of Interferon-\u03b2 and Inhibition of TLR3 Expression are associated with Fatal Outcome of Severe Fever with Thrombocytopenia Syndrome","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cid\/cit530","article-title":"Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in China who had severe fever with thrombocytopenia syndrome","volume":"57","author":"Liu","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Suemori, K., Saijo, M., Yamanaka, A., Himeji, D., Kawamura, M., Haku, T., Hidaka, M., Kamikokuryo, C., Kakihana, Y., and Azuma, T. (2021). A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009103"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jiac.2016.01.022","article-title":"Severe fever with thrombocytopenia syndrome with myocardial dysfunction and encephalopathy: A case report","volume":"22","author":"Kawaguchi","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Jung, S.I., Kim, Y.E., Yun, N.R., Kim, C.M., Kim, D.M., Han, M.A., Kim, U.J., Kim, S.E., Kim, J., and Ryu, S.Y. (2021). Effects of steroid therapy in patients with severe fever with Thrombocytopenia syndrome: A multicenter clinical cohort study. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009128"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.2169\/internalmedicine.3257-19","article-title":"Severe Fever with Thrombocytopenia Syndrome Complicated with Pseudomembranous Aspergillus Tracheobronchitis in a Patient without Apparent Risk Factors for Invasive Aspergillosis","volume":"58","author":"Sakaguchi","year":"2019","journal-title":"Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ofaa473","DOI":"10.1093\/ofid\/ofaa473","article-title":"Impact of C-Reactive Protein Levels on Differentiating of Severe Fever With Thrombocytopenia Syndrome From Japanese Spotted Fever","volume":"7","author":"Kawaguchi","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_17","unstructured":"National Institute of Infectious Diseases\u2014Japan (2021, March 01). Laboratory tests of SFTS. Infectious Agent Surveillance Report, Available online: https:\/\/www.niid.go.jp\/niid\/en\/iasr-vol35-e\/865-iasr\/4415-tpc408.html."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jiac.2018.07.009","article-title":"Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy","volume":"24","author":"Saijo","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e10848","DOI":"10.1097\/MD.0000000000010848","article-title":"Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ijid.2021.02.088","article-title":"Invasive pulmonary aspergillosis (IPA) is a frequent complication in patients with severe fever with thrombocytopaenia syndrome (SFTS): A retrospective study","volume":"105","author":"Xu","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_21","first-page":"1491","article-title":"Invasive Pulmonary Aspergillosis in Patients With Severe Fever With Thrombocytopenia Syndrome","volume":"70","author":"Bae","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cit527","article-title":"Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality","volume":"57","author":"Dokuzoguz","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"607583","DOI":"10.3389\/fimmu.2020.607583","article-title":"COVID-19: Imbalanced Immune Responses and Potential Immunotherapies","volume":"11","author":"Xie","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., and Ustianowski, A. (2021). Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(14)70718-2","article-title":"Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis","volume":"14","author":"Liu","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/jis743","article-title":"Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds","volume":"207","author":"Speth","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaci.2017.02.034","article-title":"IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity","volume":"140","author":"Cunha","year":"2017","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/5\/785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:54:44Z","timestamp":1760162084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/5\/785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["v13050785"],"URL":"https:\/\/doi.org\/10.3390\/v13050785","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]}}}